Stock comparison
BIOGEN INC. is 3.5x more valuable than QIAGEN N.V. by market capitalization ($32.60 B vs $9.43 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BIIB is larger
BIOGEN INC. is 3.5x more valuable than QIAGEN N.V. by market capitalization ($32.60 B vs $9.43 B).
Market value leader
BIIB
BIOGEN INC. is 3.5x more valuable than QIAGEN N.V. by market capitalization ($32.60 B vs $9.43 B).
Revenue leader
BIIB
QGEN: $2.09B vs BIIB: $9.89B.
Profit leader
BIIB
QGEN: $424.88M vs BIIB: $1.29B.
Margin leader
QGEN
QGEN: 20.3% vs BIIB: 13.1% net margin.
| Metric | QGEN | BIIB |
|---|---|---|
| Market cap | $9.43 B | $32.60 B |
| US-listed rank | #998 | #448 |
| Revenue (latest FY) | $2.09B | $9.89B |
| Net income (latest FY) | $424.88M | $1.29B |
| Net margin | 20.3% | 13.1% |
| P/E (trailing FY) | 22.2x | 25.2x |
| SEC filings | 500 | 2,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BIOGEN INC. is 3.5x more valuable than QIAGEN N.V. by market capitalization ($32.60 B vs $9.43 B).
In their latest fiscal years, QIAGEN N.V. reported $2.09B in revenue while BIOGEN INC. reported $9.89B.
Full pages: QIAGEN N.V. and BIOGEN INC., or browse the full rankings.